Send feedback

MRTFA p.Arg650Gln

c.1949G>A · rs377354099 · VCV1683012

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.0655 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0171%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.0655likely benign
REVEL0.038moderately benign-leaning
SaProtLLR -5.92tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 4.9GERP 0.34, phastCons 1
Regional constrainto/e 1.06unconstrained · MANE · 13 kb · p 0.043 · regional, not allelic
Overall
CADD22.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R550Q vs ClinVar R650Q) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0171% European (non-Finnish) · 200/1,171,650 alleles
Filtering AF 0.0151% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0144%
Overall 0.0154% 244/1,588,850 alleles · ultra-rare exomes 223/1,436,650 · genomes 21/152,200 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0308% 3,244
European (non-Finnish)grpmax 0.0171% 5,858
South Asian 0.0101% 9,866
African / African-American 0.0094% 10,634
East Asian 0.00912% 10,959
Admixed American 0.00521% 19,205
Ashkenazi Jewishnot grpmax-eligible 0.00345% 29,026
Finnishnot grpmax-eligible 0.0018% 55,434

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MRTFA
Protein
p.Arg650Gln
Coding
c.1949G>A
MANE Select
NM_020831
dbSNP
rs377354099
Type
single nucleotide variant
Location
chr22:40418789 (GRCh38)
Gene constraint
LOEUF 0.389 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 56.59 · 2 PDB
Full MRTFA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mrtfa-p-arg650gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown